Skip to main content

Table 1 Patient Demographics and Baseline Characteristics.

From: CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation

  All Patients (n = 87) Patients with AF (n= 37) Patients without AF (n = 50)
Age (years) 58 ± 13 59 ± 15 56 ± 11
Male gender 54 (61%) 22 (59%) 32 (64%)
Hypertension 8 (9%) 3(8%) 5(10%)
Diabetes mellitus 6 (7%) 3(8%) 3(6%)
NYHA functional class    
   I 41 (47%) 17(46%) 24(48%)
   II 38 (44%) 16(43%) 22(44%)
   III/IV 8 (9%) 4(10%) 4(8%)
Family history of HCM or sudden death 20 (23%) 9(24%) 11(22%)
Syncope 6 (7%) 4(10%) 2(4%)
Atrial fibrillation 37 (43%)   
   None 50(57%) 0 50(100%)
   Paroxysmal 27(31%) 27 (73%) 0
   Persistent 10(12%) 10 (27%) 0
Echocardiographic data    
   LV diastolic dysfunction, n (%) 35 (40%) 22 (59%) 13 (26%)
   Mitral regurgitation    
1 27 (31%) 15 (40%) 12 (24%)
≥ 2 12(14%) 7 (18%) 5 (10%)
Medications, n (%)    
   Beta-blocker 45(52%) 20 (55%) 25 (49%)
   Calcium-channel blocker 16(18%) 7 (18%) 9 (18%)
   Amiodarone 9(10%) 5(13%) 4 (8%)
  1. Data are presented as the mean value ± SD or number (%) of subjects. NYHA = New York Heart Association; HCM = hypertrophic cardiomyopathy; LV = left ventricular